War and Peace: the difficult treatment of urinary tract infections and fosfomycin trometamol
Open Access
- 1 January 2021
- journal article
- Published by Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy in Clinical Microbiology and Antimicrobial Chemotherapy
- Vol. 23 (1)
- https://doi.org/10.36488/cmac.2021.1.44-53
Abstract
The title of this review “War and peace” is not accidental and the analogies with a well-known literary masterpiece have absolutely justified ground. As in the case of Lev Tolstoy’s novel this title has a profound philosophical meaning, although at first glance it may seem quite obvious. The word «war» may well correspond to those hostile changes of microorganisms leading to the current problem of antimicrobial resistance recognized worldwide. This is the “war” we have to wage against the antibiotic-resistant bacteria today. And the «peace» in this context is considered as the world, the entire universe, all people, the whole society and its reaction to what is happening. On the other hand, the word «peace» means something opposite in meaning to the word «war». Thus, the essence of the title bears a sharp contrast between military actions and peacetime, between something that carries a threat to life and peace, or illness and recovery. Preserving original novel’s structure the authors of this review consistently consider justification of fosfomycin trometamol as a first-line drug in the treatment of acute uncomplicated cystitis in women taking into account the latest research, publications and global trends.Keywords
This publication has 15 references indexed in Scilit:
- Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infectionJournal of Antimicrobial Chemotherapy, 2020
- The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017PLOS ONE, 2019
- Antimicrobial resistance of pathogens causing community-acquired urinary tract infections in Russia: results of the multicenter study “DARMIS-2018”Clinical Microbiology and Antimicrobial Chemotherapy, 2019
- Large variation in ESBL-producing Escherichia coli carriers in six European countries including RussiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2018
- Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated CystitisCanadian Journal of Infectious Diseases and Medical Microbiology, 2016
- International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious DiseasesClinical Infectious Diseases, 2011
- Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impactCurrent Opinion in Infectious Diseases, 2010
- An Overview of the Clinical and Laboratory Standards Institute (CLSI) and Its Impact on Antimicrobial Susceptibility TestsPublished by Taylor & Francis Ltd ,2007
- Fosfomycin TromethamineDrugs, 1997
- Pharmacokinetic Profile of Fosfomycin Trometamol (Monuril)European Urology, 1987